Clinical Trial Update: Adoptive Therapy Using Antigen-Specific CD4 T-Cells [Phase 1]

View source ↗

Summary

A Phase 1 trial of adoptive therapy using antigen-specific CD4 T-cells for melanoma and sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Sarcoma

Drugs mentioned

• Antigen-specific CD4 T-cell adoptive therapy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma, Sarcoma | Phase 1 | Status: WITHDRAWN